Monthly Archives: November 2024

MHRA Class 4 Medicines Defect Information: Entyvio 108mg solution for injection in pre-filled syringe (Takeda UK Limited) Drug alert number: EL (24)A/55 Date issued: 18 November 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Entyvio 108mg solution for injection in pre-filled syringe Company name: [...]

The post MHRA Class 4 Medicines Defect Information: Entyvio 108mg solution for injection in pre-filled syringe (Takeda UK Limited) appeared first on Community Pharmacy England.

Pharmacy owners are reminded of the requirement to complete the 2024 workforce survey, which is a mandatory requirement for all pharmacy owners. Read more about the survey and how to complete it The NHS Business Services Authority sent an email to pharmacy owners containing a link to the survey in October. In some cases, for [...]

The post Reminder: complete the 2024 mandatory workforce survey appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (15/11/2024) announced the following initial list of price concessions for November 2024: Drug Pack size Price concession Apixaban 2.5mg tablets 60 £4.20 Cefalexin 500mg capsules 21 £2.67 Chloramphenicol [...]

The post November 2024 Price Concessions 1st Update appeared first on Community Pharmacy England.

Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video providing guidance on how to correctly endorse and claim for any supplies made against a Serious Shortage Protocol (SSP). This is part of Community Pharmacy England’s ‘Funding & Reimbursement Shorts’ series, which has been created to provide pharmacy owners and their [...]

The post Funding & Reimbursement Shorts: Dispensing and Claiming SSPs appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Monomax® XL 60mg tablets is now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP074 Monomax® XL 60mg tablets expires at 23.59pm on Friday 15 November 2024. After this date, any prescriptions for Monomax® XL 60mg tablets [...]

The post Expiry of SSP074 Monomax® XL 60mg tablets appeared first on Community Pharmacy England.